MENU
Showcases Stock ranks Forex

Iterum Therapeutics Plc (ITRM)
0.5221  -0.031 (-5.62%) 10-22 16:00
Open: 0.53 Pre. Close: 0.5532
High: 0.535 Low: 0.521
Volume: 3,308,208 Market Cap: 94M
Iterum Therapeutics Plc is a pharmaceutical company which engages in the development and commercialization of sulopenem to be potentially the first and only oral and intravenous (IV) branded penem available. The company is headquartered in Dublin, Dublin and currently employs 48 full-time employees. The firm is focused on developing significantly differentiated anti-infectives aimed at combatting the global crisis of multi-drug resistant (MDR) pathogens. The firm is developing sulopenem - the oral and intervenous (IV) penem antibiotic demonstrating a potent spectrum of activity against multi-drug resistant gram-negative. The company is a bioavailable, antibiotic covering gram-positive, gram-negative and anaerobic pathogen with in-vitro activity against multidrug-resistant pathogens, including Extended-Spectrum Beta-Lactamase (ESBL)-producing Escherichia, coli and Klebsiella and pneumonia. The company has demonstrated potent in vitro activity against all genera of Enterobacteriacease, in anaerobes such as Bacteroides, Prevotella, Porphyromonas, Fusobacterium and Peptostreptococcus, gram-positive organisms including methicillin-susceptible staphylococci, Streptococcus pyogenes and Streptococcus pneumonia.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 0.541 - 0.544 0.544 - 0.546
Low: 0.513 - 0.516 0.516 - 0.519
Close: 0.515 - 0.521 0.521 - 0.525
Stock Technical Analysis
Overall:     
Target: Six months: 0.71
One year: 0.78
Support: Support1: 0.51
Support2: 0.43
Resistance: Resistance1: 0.61
Resistance2: 0.67
Pivot: 0.54
Moving Averages: MA(5): 0.54
MA(20): 0.55
MA(100):
MA(250): 1.13
MACD: MACD(12,26): -0.02
Signal(12,26,9): -0.03
%K %D: %K(14,3): 24.88
%D(3): 23.59
RSI: RSI(14): 38.93
52-Week: High: 2.995
Low: 0.451
Change(%): 0.4
Average Vol(K): 3-Month: 423035
10-Days: 262825
Price, MAs and Bollinger Bands
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.

ITRM has closed above bottom band by 14.8%. Bollinger Bands are 92.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to ITRM's normal range. The bands have been in this narrow range for 50 bars. This is a sign that the market may be about to initiate a new trend.
Stock chart
Stock News
Thu, 21 Oct 2021
Iterum Therapeutics plc (ITRM): Find Out What Insiders Are Doing - The Fosters Leader

Mon, 04 Oct 2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Iterum Therapeutics Plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 4, 2021 - ITRM - Yahoo Finance

Mon, 04 Oct 2021
Looking To Buy Iterum Therapeutics plc (ITRM)? Read This First - The Fosters Leader

Fri, 01 Oct 2021
Where Does Iterum Therapeutics PLC (ITRM) Stock Fall in the Biotechnology Field After It Is Up 14.81% This Week? - InvestorsObserver

Fri, 01 Oct 2021
Monday Deadline for Investors to Actively Participate in Iterum Therapeutics plc (ITRM) Class Action - Bronstein, Gewirtz & Grossman, LLC - Business Wire

Thu, 30 Sep 2021
ITRM Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Iterum Therapeutics plc Shareholders of Class Action and Lead Plaintiff Deadline: October 4, 2021 - Yahoo Finance

Financial Analysis
Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  Nasdaq Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 179.14
Shares Float (M) 176.16
% Held by Insiders 0.59
% Held by Institutions 9.58
Shares Short (K) 2910
Shares Short Prior Month (K) 3550
Stock Financials
EPS -2.660
Book Value (p.s.) 0.180
Profit Margin
Operating Margin
Return on Assets (ttm) -19.9
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.139
Qtrly Earnings Growth
Operating Cash Flow (M) -28.27
Levered Free Cash Flow (M) -12.46
Stock Valuation
PE Ratio -0.20
PEG Ratio
Price to Book value 2.90
Price to Sales
Price to Cash Flow -3.31
Stock Dividends
Dividend
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator